DSV, 1134 - DSV RECEIVES BOTH SELLER APPROVALS TO ACQUIRE SCHENKER


(MENAFN- GlobeNewsWire - Nasdaq) Company Announcement No. 1134

With reference to DSV's company announcement no. 1132 on 13 September 2024 DSV A/S (“DSV”) has received confirmation that both conditions precedent for the seller Deutsche Bahn (“DB”) have been satisfied. The transaction remains conditional on obtaining customary regulatory approvals.

DB has in accordance with the announced transaction arrangements confirmed that both the Supervisory Board of DB and the German federal Ministry for Digital and transport (Bundesministerium für Digitales und Verkehr) have approved the sale of Schenker AG (“Schenker”) to DSV.

The transaction remains conditional on obtaining customary regulatory approvals, and completion of the transaction is expected in Q2 2025.

Jens H. Lund, CEO of DSV, comments:
"We are very pleased that Deutsche Bahn has confirmed that their two conditions for approving the sale of Schenker to DSV have been obtained. This means that we can continue our efforts to be ready for closing this transformational transaction according to the agreed plans. We thank Deutsche Bahn for professionally getting us to this stage, and we are enthusiastic about working towards creating a leading global player in the transport and logistic industry.”

Contacts DSV:
Investor Relations
Stig Frederiksen, tel. +45 43 20 36 38, ...
Alexander Plenborg, tel. +45 43 20 33 73, ...

Media
Jonatan Rying Larsen, tel. +45 25 41 77 37, ...

Yours sincerely,
DSV

Attachment

  • 1134 - Announcement (02.10.2024) - DSV RECEIVES BOTH SELLER APPROVALS TO ACQUIRE SCHENKER

MENAFN02102024004107003653ID1108739249


GlobeNewsWire - Nasdaq

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.